Nanoparticles: Oral Delivery for Protein and Peptide Drugs
2019 · AAPS PharmSciTech · 294 citations
https://doi.org/10.1208/s12249-019-1325-z
Y
Yong Ling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
227
Papers
4.5K
Citations
36
h-index
110
i10-index
Yong Ling is an academic researcher from Nantong University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Synthesis and biological activity & Histone Deacetylase Inhibitors Research. The author has an h-index of 36, co-authored 193 publications.
ORCID: 0000-0002-3373-011XPapers by this author
worksDesign, synthesis and biological evaluation of hybrids of β-carboline and salicylic acid as potential anticancer and apoptosis inducing agents
2016 · Scientific Reports · 34 citations
https://doi.org/10.1038/srep36238
Advances in microRNA from adipose-derived mesenchymal stem cell-derived exosome: focusing on wound healing
2022 · Journal of Materials Chemistry B · 34 citations
https://doi.org/10.1039/d2tb01987f
Time-economical synthesis of selenofunctionalized heterocycles <i>via</i> I<sub>2</sub>O<sub>5</sub>-mediated selenylative heterocyclization
2021 · Organic & Biomolecular Chemistry · 33 citations
https://doi.org/10.1039/d1ob02196f
Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models
2021 · iScience · 31 citations
https://doi.org/10.1016/j.isci.2021.102302
Hybrids from Farnesylthiosalicylic Acid and Hydroxamic Acid as Dual Ras‐Related Signaling and Histone Deacetylase (HDAC) Inhibitors: Design, Synthesis and Biological Evaluation
2015 · ChemMedChem · 29 citations
https://doi.org/10.1002/cmdc.201500019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat